Old Web
English
Sign In
Acemap
>
authorDetail
>
Kristen Schlueter
Kristen Schlueter
Cleveland Clinic
Internal medicine
Medicine
Immunology
Oncology
Multiple myeloma
4
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Updated Organ Response Results of an Open-Label Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis Receiving Anti-Plasma Cell Therapy
2021
Blood
Jason Valent
John Silowsky
Michael R. Kurman
Eileen Daniel
Janet Jobes
Mark Harnett
Sherry Fada
Michael Spector
Kathleen Stefunek
Heather Staley
Kristen Schlueter
Christy J. Samaras
Faiz Anwer
Jack Khouri
Jeffrey A. Zonder
Michaela Liedtke
Susan B. Sobolov
Show All
Source
Cite
Save
Citations (0)
Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma
2020
British Journal of Haematology
Diana Basali
Rajshekhar Chakraborty
Lisa Rybicki
Nathaniel Rosko
Janice Reed
M. A. Karam
Kristen Schlueter
Hayley Dysert
Matt Kalaycio
Jason Valent
Show All
Source
Cite
Save
Citations (8)
External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients
2019
Blood
Fahrettin Covut
Ramsha Ahmed
Christy Samaras
Faiz Anwer
Alex V. Mejia Garcia
Dana E. Angelini
Beth Faiman
Janice Reed
Mary Ann Karam
Kristen Schlueter
Saveta Mathur
Kimberly Hamilton
Nathaniel Rosko
Jason Valent
Jack Khouri
Show All
Source
Cite
Save
Citations (1)
Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma
2019
Blood
Diana Basali
Rajshekhar Chakraborty
Lisa Rybicki
Nathaniel Rosko
Janice Reed
Mary Ann Karam
Kristen Schlueter
Hayley Dysert
Beth Faiman
Kimberly Hamilton
Matt Kalaycio
Jason Valent
Show All
Source
Cite
Save
Citations (0)
1